ENGINEERINGNET.EU -- IBA, a high-tech company specialized in radiation therapy and diagnostics for the treatment of cancer, announces that its medical and industrial accelerators business unit has signed three new contract for the delivery of Rhodotrons in Asia.
The Rhodotron machines will primarily be used for the sterilization of medical devices using electron beam technology.
The key advantage of IBA’s technology in comparison to radioactive or chemical based sterilization processes, is that its Electron Beam process is fast and free from any contamination by chemicals and radioactive materials.
Olivier Legrain, Chief Executive Officer of IBA commented: “The growing Asian markets and the drive in the region for better sterilization processes represent a good opportunity for IBA’s medical and industrial accelerators business."
"We will continue to focus on bringing our leading edge technologies to this region and look forward to announcing further successes later in the year.”
Thanks to its high power, the Rhodotron is the only electron beam accelerator able to process large scale sterilization volumes, states IBA. The company has sold more than 30 machines worldwide to major medical device manufacturers and sterilization service centers.
BACKGROUND
Headquartered in Belgium and employing more than 1,200 people worldwide, IBA currently has installed systems across Europe and the US and is expanding into emerging markets.
